160 related articles for article (PubMed ID: 9864382)
41. Genetic changes that affect the virulence of measles virus in a rhesus macaque model.
Bankamp B; Hodge G; McChesney MB; Bellini WJ; Rota PA
Virology; 2008 Mar; 373(1):39-50. PubMed ID: 18155263
[TBL] [Abstract][Full Text] [Related]
42. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
[TBL] [Abstract][Full Text] [Related]
43. Is mRNA and protein level of CD46 altered in measles virus vaccine strain S191-infected cells?
Hu C; Qi Y; Zhang P; Liu X; Xu Q; Chen X
Biochem Biophys Res Commun; 2004 Sep; 322(3):794-802. PubMed ID: 15336534
[TBL] [Abstract][Full Text] [Related]
44. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient.
Takeuchi K; Miyajima N; Kobune F; Tashiro M
Virus Genes; 2000; 20(3):253-7. PubMed ID: 10949953
[TBL] [Abstract][Full Text] [Related]
45. Adaptation of wild-type measles virus to tissue culture.
Kouomou DW; Wild TF
J Virol; 2002 Feb; 76(3):1505-9. PubMed ID: 11773423
[TBL] [Abstract][Full Text] [Related]
46. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).
Liszewski MK; Leung M; Cui W; Subramanian VB; Parkinson J; Barlow PN; Manchester M; Atkinson JP
J Biol Chem; 2000 Dec; 275(48):37692-701. PubMed ID: 10960475
[TBL] [Abstract][Full Text] [Related]
47. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.
Manchester M; Gairin JE; Patterson JB; Alvarez J; Liszewski MK; Eto DS; Atkinson JP; Oldstone MB
Virology; 1997 Jun; 233(1):174-84. PubMed ID: 9201227
[TBL] [Abstract][Full Text] [Related]
48. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.
Naniche D; Varior-Krishnan G; Cervoni F; Wild TF; Rossi B; Rabourdin-Combe C; Gerlier D
J Virol; 1993 Oct; 67(10):6025-32. PubMed ID: 8371352
[TBL] [Abstract][Full Text] [Related]
49. Toward understanding the pathogenicity of wild-type measles virus by reverse genetics.
Takeuchi K; Takeda M; Miyajima N
Jpn J Infect Dis; 2002 Oct; 55(5):143-9. PubMed ID: 12501253
[TBL] [Abstract][Full Text] [Related]
50. The human CD46 molecule is a receptor for measles virus (Edmonston strain).
Dörig RE; Marcil A; Chopra A; Richardson CD
Cell; 1993 Oct; 75(2):295-305. PubMed ID: 8402913
[TBL] [Abstract][Full Text] [Related]
51. Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection.
Yant S; Hirano A; Wong TC
J Virol; 1997 Jan; 71(1):766-70. PubMed ID: 8985414
[TBL] [Abstract][Full Text] [Related]
52. Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain.
Seki F; Takeda M; Minagawa H; Yanagi Y
J Gen Virol; 2006 Jun; 87(Pt 6):1643-1648. PubMed ID: 16690929
[TBL] [Abstract][Full Text] [Related]
53. Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation.
Bartz R; Brinckmann U; Dunster LM; Rima B; Ter Meulen V; Schneider-Schaulies J
Virology; 1996 Oct; 224(1):334-7. PubMed ID: 8862431
[TBL] [Abstract][Full Text] [Related]
54. CD46 transgene expression in pig peripheral blood mononuclear cells does not alter their susceptibility to measles virus or their capacity to downregulate endogenous and transgenic CD46.
Schneider-Schaulies J; Martin MJ; Logan JS; Firsching R; ter Meulen V; Diamond LE
J Gen Virol; 2000 Jun; 81(Pt 6):1431-8. PubMed ID: 10811926
[TBL] [Abstract][Full Text] [Related]
55. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function.
Liszewski MK; Leung MK; Atkinson JP
J Immunol; 1998 Oct; 161(7):3711-8. PubMed ID: 9759896
[TBL] [Abstract][Full Text] [Related]
56. Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46).
Iwata K; Seya T; Ueda S; Ariga H; Nagasawa S
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):169-75. PubMed ID: 7998929
[TBL] [Abstract][Full Text] [Related]
57. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y
J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026
[TBL] [Abstract][Full Text] [Related]
58. Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).
Seya T; Kurita M; Hara T; Iwata K; Semba T; Hatanaka M; Matsumoto M; Yanagi Y; Ueda S; Nagasawa S
Immunology; 1995 Apr; 84(4):619-25. PubMed ID: 7790036
[TBL] [Abstract][Full Text] [Related]
59. A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus.
Christiansen D; De Sousa ER; Loveland B; Kyriakou P; Lanteri M; Wild FT; Gerlier D
J Gen Virol; 2002 May; 83(Pt 5):1147-1155. PubMed ID: 11961270
[TBL] [Abstract][Full Text] [Related]
60. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells.
Schneider-Schaulies J; Schnorr JJ; Schlender J; Dunster LM; Schneider-Schaulies S; ter Meulen V
J Virol; 1996 Jan; 70(1):255-63. PubMed ID: 8523534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
